» Articles » PMID: 25741752

Dimeric Drug Polymeric Nanoparticles with Exceptionally High Drug Loading and Quantitative Loading Efficiency

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2015 Mar 6
PMID 25741752
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Encapsulation of small-molecule drugs in hydrophobic polymers or amphiphilic copolymers has been extensively used for preparing polymeric nanoparticles (NPs). The loadings and loading efficiencies of a wide range of drugs in polymeric NPs, however, tend to be very low. In this Communication, we report a strategy to prepare polymeric NPs with exceptionally high drug loading (>50%) and quantitative loading efficiency. Specifically, a dimeric drug conjugate bearing a trigger-responsive domain was designed and used as the core-constructing unit of the NPs. Upon co-precipitation of the dimeric drug and methoxypoly(ethylene glycol)-block-polylactide (mPEG-PLA), NPs with a dimeric drug core and a polymer shell were formed. The high-drug-loading NPs showed excellent stability in physiological conditions. No premature drug or prodrug release was observed in PBS solution without triggering, while external triggering led to controlled release of drug in its authentic form.

Citing Articles

Triethylamine-mediated protonation-deprotonation unlocks dual-drug self assembly to suppress breast cancer progression and metastasis.

Lei L, Song Y, Yang L, Wang Y, Xia X, Zhang Y Proc Natl Acad Sci U S A. 2025; 122(5):e2416796122.

PMID: 39874295 PMC: 11804646. DOI: 10.1073/pnas.2416796122.


Tumor microenvironment-responsive nanoformulations for breast cancer.

Velapure P, Kansal D, Bobade C Discov Nano. 2024; 19(1):212.

PMID: 39708097 PMC: 11663212. DOI: 10.1186/s11671-024-04122-5.


Nanomaterial-enabled drug transport systems: a comprehensive exploration of current developments and future avenues in therapeutic delivery.

Basu S, Biswas P, Anto M, Singh N, Mukherjee K 3 Biotech. 2024; 14(12):289.

PMID: 39507057 PMC: 11534931. DOI: 10.1007/s13205-024-04135-y.


Light-Activated Anti-Vascular Combination Therapy against Choroidal Neovascularization.

Xu S, Li J, Long K, Liang X, Wang W Adv Sci (Weinh). 2024; 11(40):e2404218.

PMID: 39206706 PMC: 11516295. DOI: 10.1002/advs.202404218.


Dimeric Drug Polymeric Micelles with Acid-Active Tumor Targeting and FRET-indicated Drug Release.

Guo X, Wang L, Duval K, Fan J, Zhou S, Chen Z ArXiv. 2024; .

PMID: 39130205 PMC: 11312624.